Cargando…

Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism

Human p53 protein acts as a transcription factor predominantly in a tetrameric form. Single residue changes, caused by hot-spot mutations of the TP53 gene in human cancer, transform wild-type (wt) p53 tumor suppressor proteins into potent oncoproteins - with gain-of-function, tumor-promoting activit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walerych, Dawid, Pruszko, Magdalena, Zyla, Lukasz, Wezyk, Michalina, Gaweda-Walerych, Katarzyna, Zylicz, Alicja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112834/ https://www.ncbi.nlm.nih.gov/pubmed/30174797 http://dx.doi.org/10.18632/oncotarget.25944

Ejemplares similares

Mutant p53: One, No One, and One Hundred Thousand
por: Walerych, Dawid, et al.
Publicado: (2015)

The rebel angel: mutant p53 as the driving oncogene in breast cancer
por: Walerych, Dawid, et al.
Publicado: (2012)

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
por: Lisek, Kamil, et al.
Publicado: (2018)

A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer
por: Grzes, Maria, et al.
Publicado: (2020)

Diverse and cancer type-specific roles of the p53 R248Q gain-of-function mutation in cancer migration and invasiveness
por: Olszewski, Maciej Boleslaw, et al.
Publicado: (2019)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

p53’s Extended Reach: The Mutant p53 Secretome
por: Pavlakis, Evangelos, et al.
Publicado: (2020)

Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2012)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.
por: Brown, J. M.
Publicado: (1998)

Preferential Binding of Hot Spot Mutant p53 Proteins to Supercoiled DNA In Vitro and in Cells
por: Brázdová, Marie, et al.
Publicado: (2013)

Correction: Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2013)

Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities
por: Annor, George K., et al.
Publicado: (2021)

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

Selective targeting of p53 gain-of-function mutants in cancer
por: Padmanabhan, Achuth
Publicado: (2018)

Gain-of-function mutant p53 in cancer progression and therapy
por: Zhang, Cen, et al.
Publicado: (2020)

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

p53 tetramerization: at the center of the dominant-negative effect of mutant p53
por: Gencel-Augusto, Jovanka, et al.
Publicado: (2020)

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12
por: Jia, Shuting, et al.
Publicado: (2012)

Big bones in p53 mutants
por: LeBrasseur, Nicole
Publicado: (2006)

Mutant p53 succumbs to starvation
por: Moon, Sung-Hwan, et al.
Publicado: (2013)

Chromatin dysregulation by mutant p53
por: Pfister, Neil T., et al.
Publicado: (2016)

Mutant p53 partners in crime
por: Kim, Michael P, et al.
Publicado: (2018)

Mutant p53 in colon cancer
por: Nakayama, Mizuho, et al.
Publicado: (2018)

Gain of function of mutant p53: R282W on the peak?
por: Zhang, Y, et al.
Publicado: (2016)

Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
por: Schulz-Heddergott, Ramona, et al.
Publicado: (2018)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
por: Stein, Yan, et al.
Publicado: (2019)

Regulation of Mutant p53 Protein Expression
por: Vijayakumaran, Reshma, et al.
Publicado: (2015)

Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016)

SNPing away at mutant p53 activities
por: Ortiz, Guadalupe J., et al.
Publicado: (2018)

Mutant p53 as an Antigen in Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2020)

Mutant p53 in cell-cell interactions
por: Pilley, Steven, et al.
Publicado: (2021)

Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer
por: Bellazzo, Arianna, et al.
Publicado: (2015)

Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
por: Pedrote, Murilo M., et al.
Publicado: (2020)

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
por: Redman-Rivera, Lindsay N., et al.
Publicado: (2021)

Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer
por: Madrigal, Tzitzijanik, et al.
Publicado: (2021)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q9corlgo3op5toc9k1gu2tpouj